42 related articles for article (PubMed ID: 476236)
21. Combination of phenobarbital and haloperidol in resistant schizophrenia.
Prakash R; Reed RM; Bass AD
J Clin Psychopharmacol; 1984 Dec; 4(6):362-3. PubMed ID: 6512009
[No Abstract] [Full Text] [Related]
22. Use of verapamil to treat negative symptoms in schizophrenia.
Price WA; Pascarzi GA
J Clin Psychopharmacol; 1987 Oct; 7(5):357. PubMed ID: 3680609
[No Abstract] [Full Text] [Related]
23. Letter: Are benzodiazepines antipsychotic agents?
Nistri A
Lancet; 1975 Nov; 2(7943):1040. PubMed ID: 53525
[No Abstract] [Full Text] [Related]
24. Letter: Are benzodiazepines antipsychotic agents?
Trabucchi M; Ba G
Lancet; 1975 Nov; 2(7940):868. PubMed ID: 53347
[No Abstract] [Full Text] [Related]
25. Case report: psychomotor status-like episodes under haloperidol treatment.
Kaminer Y; Munitz H
Br J Psychiatry; 1984 Jul; 145():87-8. PubMed ID: 6743950
[No Abstract] [Full Text] [Related]
26. "Valium" in the treatment of schizophrenia.
Irvine BM
Med J Aust; 1969 Jun; 1(26):1387. PubMed ID: 5797176
[No Abstract] [Full Text] [Related]
27. Benzodiazepines for schizophrenia.
Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236
[TBL] [Abstract][Full Text] [Related]
28. Treatment of the special patient with schizophrenia.
Conley RR; Kelly DL
Dialogues Clin Neurosci; 2001 Jun; 3(2):123-35. PubMed ID: 22034474
[TBL] [Abstract][Full Text] [Related]
29. Concept and Management of Treatment Resistant Schizophrenia (TRS).
Painuly N; Gupta N; Avasthi A
Indian J Psychiatry; 2004 Apr; 46(2):125-34. PubMed ID: 21408038
[TBL] [Abstract][Full Text] [Related]
30. Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
McLeod MC; Sundram S; Dean B
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):560-7. PubMed ID: 18045761
[TBL] [Abstract][Full Text] [Related]
31. Benzodiazepines in chronic schizophrenia.
Ruskin P; Averbukh I; Belmaker RH; Dasberg H
Biol Psychiatry; 1979 Jun; 14(3):557-8. PubMed ID: 476236
[No Abstract] [Full Text] [Related]
32. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
Akhondzadeh S; Nejatisafa AA; Amini H; Mohammadi MR; Larijani B; Kashani L; Raisi F; Kamalipour A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1007-12. PubMed ID: 14499318
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic effect of cannabidiol.
Zuardi AW; Morais SL; Guimarães FS; Mechoulam R
J Clin Psychiatry; 1995 Oct; 56(10):485-6. PubMed ID: 7559378
[No Abstract] [Full Text] [Related]
35. [Treatment of several psychotic states with the combination of valproic acid with diazepam].
Bourguignon A; Monfort JC; de Medeiros P; Cadet B; Chaneac D
Ann Med Psychol (Paris); 1984 Nov; 142(9):1214-8. PubMed ID: 6442960
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
